STORM Therapeutics Presents STC-15 Preclinical Data Supporting Treatment of Patients with AML at the AACR Acute Myeloid Leukemia and Myelodysplastic Syndrome Conference

/PRNewswire/ -- STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule therapies targeting...

Related Keywords

Cambridge ,Cambridgeshire ,United Kingdom ,United States ,Texas ,American ,Oliver Rausch ,Coralie Hoareau Aveilla ,Jerry Mcmahon ,Lina Vasiliauskait ,Mark Albertella ,Utokyo Innovation Platform Co Ltd ,Therapeutics Ltd ,Taiho Ventures ,American Association For Cancer Research ,Storm Therapeutics Ltd ,Ip Group ,Fast Track Initiative ,Cambridge Innovation Capital ,Seroba Life Sciences ,American Association ,Cancer Research ,Special Conference ,Acute Myeloid Leukemia ,Myelodysplastic Syndrome ,Chief Scientific Officer ,Chief Executive Officer ,Presented Title ,Pfizer Ventures ,Cambridge Innovation Capitali Limited ,Storm Therapeutics ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Biotechnology ,Pharmaceuticals ,Clinical Trials Amp Medical Discoveries ,Trade Show News ,